CXCL12 and CXCR4 in adenocarcinoma of the lung: Association with metastasis and survival

Journal of Thoracic and Cardiovascular Surgery

Volumn 137, Issue 3, 2009, Pages 615-621

  Wagner, Patrick L ^a   Hyjek, Elizabeth ^c   Vazquez, Madeline F ^a   Meherally, Danish ^b   Liu, Yi Fang ^a   Chadwick, Paul A ^a   Rengifo, Tatiana ^a   Sica, Gabriel L ^a   Port, Jeffrey L ^b   Lee, Paul C ^b   Paul, Subroto ^b   Altorki, Nasser K ^b   Saqi, Anjali ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; STROMAL CELL DERIVED FACTOR 1;

AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELLULAR DISTRIBUTION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADENOCARCINOMA; AGED; CHEMOKINE CXCL12; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; RECEPTORS, CXCR4; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 60949093573     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.07.039     Document Type: Article

References (24)

1. Zlotnik A. Involvement of chemokine receptors in organ-specific metastasis. Contrib Microbiol 13 (2006) 191-199
2. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410 (2001) 50-56
3. Phillips R.J., Burdick M.D., Lutz M., Belperio J.A., Keane M.P., and Strieter R.M. The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med 167 (2003) 1676-1686
4. Petty J.M., Sueblinvong V., Lenox C.C., Jones C.C., Cosgrove G.P., Cool C.D., et al. Pulmonary stromal-derived factor-1 expression and effect on neutrophil recruitment during acute lung injury. J Immunol 178 (2007) 8148-8157
5. In: Travis W.D., Muller-Mermelink H.K., and Harris C.C. (Eds). Pathology and genetics of tumours of the lung, thymus, and heart (2004), IARC Press, Geneva
6. Greene F.L. American Joint Committee on Cancer. AJCC cancer staging atlas (2006), Springer, New York
7. Gokhale S., Rosen D., Sneige N., Diaz L.K., Resetkova E., Sahin A., et al. Assessment of two automated imaging systems in evaluating estrogen receptor status in breast carcinoma. Appl Immunohistochem Mol Morphol 15 (2007) 451-455
8. Turbin D.A., Leung S., Cheang M.C., Kennecke H.A., Montgomery K.D., McKinney S., et al. Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases. Breast Cancer Res Treat 110 (2008) 417-426
9. Su L., Zhang J., Xu H., Wang Y., Chu Y., Liu R., et al. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells. Clin Cancer Res 11 (2005) 8273-8280
10. Spano J.P., Andre F., Morat L., Sabatier L., Besse B., Combadiere C., et al. Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome. Ann Oncol 15 (2004) 613-617
11. Miyakis S., Liloglou T., Kearney S., Xinarianos G., Spandidos D.A., and Field J.K. Absence of mutations in the VHL gene but frequent loss of heterozygosity at 3p25-26 in non-small cell lung carcinomas. Lung Cancer 39 (2003) 273-277
12. Weir B.A., Woo M.S., Getz G., Perner S., Ding L., Beroukhim R., et al. Characterizing the cancer genome in lung adenocarcinoma. Nature 450 (2007) 893-898
13. Phillips R.J., Mestas J., Gharaee-Kermani M., Burdick M.D., Sica A., Belperio J.A., et al. Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha. J Biol Chem 280 (2005) 22473-22481
14. Zagzag D., Krishnamachary B., Yee H., Okuyama H., Chiriboga L., Ali M.A., et al. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor. Cancer Res 65 (2005) 6178-6188
15. Wald O., Izhar U., Amir G., Avniel S., Bar-Shavit Y., Wald H., et al. CD4+CXCR4highCD69+ T cells accumulate in lung adenocarcinoma. J Immunol 177 (2006) 6983-6990
16. Borrello M.G., Alberti L., Fischer A., Degl'innocenti D., Ferrario C., Gariboldi M., et al. Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene. Proc Natl Acad Sci U S A 102 (2005) 14825-14830
17. Castellone M.D., Guarino V., De Falco V., Carlomagno F., Basolo F., Faviana P., et al. Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas. Oncogene 23 (2004) 5958-5967
18. Kubarek L., and Jagodzinski P.P. Epigenetic up-regulation of CXCR4 and CXCL12 expression by 17 beta-estradiol and tamoxifen is associated with formation of DNA methyltransferase 3B4 splice variant in Ishikawa endometrial adenocarcinoma cells. FEBS Lett 581 (2007) 1441-1448
19. Pan H., Luo C., Li R., Qiao A., Zhang L., Mines M., et al. Cyclophilin A is required for CXCR4-mediated nuclear export of heterogeneous nuclear ribonucleoprotein A2, activation and nuclear translocation of ERK1/2, and chemotactic cell migration. J Biol Chem 283 (2008) 623-637
20. Zhao M., Discipio R.G., Wimmer A.G., and Schraufstatter I.U. Regulation of CXCR4-mediated nuclear translocation of extracellular signal-related kinases 1 and 2. Mol Pharmacol 69 (2006) 66-75
21. Conde E., Angulo B., Tang M., Morente M., Torres-Lanzas J., Lopez-Encuentra A., et al. Molecular context of the EGFR mutations: evidence for the activation of mTOR/S6K signaling. Clin Cancer Res 12 (2006) 710-717
22. Salvucci O., Bouchard A., Baccarelli A., Deschenes J., Sauter G., Simon R., et al. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study. Breast Cancer Res Treat 97 (2006) 275-283
23. Fujii N., Nakashima H., and Tamamura H. The therapeutic potential of CXCR4 antagonists in the treatment of HIV. Expert Opin Investig Drugs 12 (2003) 185-195
24. Liles W.C., Broxmeyer H.E., Rodger E., Wood B., Hubel K., Cooper S., et al. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 102 (2003) 2728-2730